AzTrials
AzTrials

Geriatric Health ServicesRESILIENTNCT06490783

Cyber-Human Systems for Personalized Well-being and Health

An observational study of Geriatric Health Services and Health Services for the Elderly, run by Istituto per la Ricerca e l'Innovazione Biomedica at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of the present study is to evaluate the effectiveness of using multi-parameter monitoring devices in the elderly to improve their quality of life not already understood as the absence of disease but in a logic that is intrinsically linked to the body-mind relationship, which is increasingly significant as… Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Noninvasive wearable devices (smartwatch and heart rate monitor band)
How many people
10 participants
Where
1 siteItaly
Study dates
1 Jul 2024to 31 May 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The elderly population plays a significant role in society, influencing social, economic, and cultural aspects. Intellectual stimulation and social interactions are crucial for keeping their minds active and preventing isolation, decline and depression. Physical activity can help to maintain strength and balance, preventing motor decline and reducing the risk of falls and injuries. Issues such as loss of intrinsic abilities, exposure to adversity, and functional deterioration can cause psychological distress. Common concerns among the elderly include health changes, loss of loved ones, income reduction, and a diminished sense of purpose after retirement. A proactive approach to health management and a strong support system can significantly enhance the overall well-being of the elderly.

Who may be able to join

  • healthy male and female aged 60 years and older
  • signing of informed consent

Who cannot join

  • chronic diseases
  • cardiovascular disease
  • presence of dementia and/or depression
  • presence of confirmed paranoid or psychotic symptoms

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Maria Valeria Maiorana contact

mariavaleria.maiorana@irib.cnr.it

Italy1 site, 1 recruiting
  • Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR), Messina 98164, Italy

    Messina, 98164

    Serena Iacono Isidoro, serena.iaconoisidoro@irib.cnr.it

    Gennaro Tartarisco

    Recruiting

Other trials in Italy

About this study

Official title: CybeR-human systEms for perSonalIzed mentaL and physIcal wEll-beiNg and Health

The purpose of the present study is to evaluate the effectiveness of using multi-parameter monitoring devices in the elderly to improve their quality of life not already understood as the absence of disease but in a logic that is intrinsically linked to the body-mind relationship, which is increasingly significant as biological age advances. The study will be conducted on a sample of volunteer elderly subjects who will wear devices capable of constantly monitoring vital parameters such as heart rate, physical activity, sleep quality, stress levels and higher level activities, linked sensory and cognitive aspects ecologically integrated with the elderly person's living environment, in the sense of an evaluative and qualitative focus on relationships within the person's area of action/interaction, possibly supported and stimulated by individualized and easily usable activities. The signals interpreted and returned by the technology to the elderly person who uses it can also act as a reassuring self-assessment of even normal body states, sometimes experienced as threatening and anxiogenic, thus stressful. The collection and management of these data may serve as a reference to the recognition of distress signals and complex experiences (e.g., depressive) that normally have significant effects on mental health, understood as intrinsically linked to the health of the body.

Being tested
Noninvasive wearable devices (smartwatch and heart rate monitor band)
Keywords
elderly, wellbeing, Artificial Intelligence, quality of life, AI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Noninvasive wearable devices (smartwatch and heart rate monitor band)Other

    Each enrolled subject will be equipped with noninvasive wearable devices (smartwatch and heart rate monitor band) to monitor physiological parameters and emotional states related to anxiety and stress. Each subject will be required to wear the smartwatch on his or her wrist for the duration of the study, about 3-6 months; while the heart rate monitor band will be worn for about 10 minutes a day. At the same time, a mobile application, RESILIENT, will be developed and implemented to serve as the main interface for self-assessment data entry and for feedback and recommendations.

    The psycho-physical condition of each subject will be monitored by the app through customized and contextualized mental exercises based on daily activities. This approach will test the effectiveness of the proposed architecture in reducing unhealthy habits and promoting health and wellness recommendations

Study groups in NCT06490783
Study groupRoleWhat they receive
healthy elderlyThe sample consists of healthy elderly volunteers who will wear noninvasive wearable devices (smartwatch and heart rate monitor band) to monitor physiological parameters and emotional states related to anxiety and stress.
Receives: Other: Noninvasive wearable devices (smartwatch and heart rate monitor band)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart Rate(HR)

    The chest strap Polar H10 uses an electrocardiogram (ECG) sensor to detect the electrical activity of the heart and calculate heart rate in beats per minute (bpm).

    Measured: Through study completion, an average of 1 year

  2. Heart rate variability (HRV)

    The chest strap Polar H10 measures the time intervals between successive heart beats and calculates Heart Rate Variability (HRV) in milliseconds (ms).

    Measured: Through study completion, an average of 1 year

  3. Facial emotion recognition

    The smartphone's camera records facial expressions in order to evaluate and quantify human emotions.

    The Artificial Intelligence (AI) algorithms, recognizing the human face, identify important facial features and examine them to categorize different facial emotions. The emotions associated with these facial expressions are then extracted.

    Measured: Through study completion, an average of 1 year

  4. Steps taken

    This refers to the total number of times each subject take a step with either foot. It's a basic unit to measure overall activity level. Fitness trackers typically use steps to monitor movement throughout the day.

    Measured: Through study completion, an average of 1 year

  5. Distance traveled

    This indicates the actual physical length each subject covered during activity. It's usually measured in miles or kilometers. Distance traveled can be calculated based on the number of steps you take and your stride length (the distance between two consecutive footfalls with the same foot).

    Measured: Through study completion, an average of 1 year

  6. Calories burned

    This refers to the amount of energy each subject's body expends during activity. It's measured in calories (kcal). The number of calories burned depends on various factors like weight, height, activity intensity (e.g., walking vs running), and duration. Fitness trackers typically estimate calorie burn based on steps taken, distance traveled, and personal information.

    Measured: Through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2024
  2. Study start1 Jul 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06490783
Sponsor's protocol ID
CNR-IRIB-PRO-2024-009
Acronym
RESILIENT
Status last verified
Apr 2025
First submitted
17 Jun 2024
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Abd-Alrazaq A, Alhuwail D, Schneider J, Toro CT, Ahmed A, Alzubaidi M, Alajlani M, Househ M. The performance of artificial intelligence-driven technologies in diagnosing mental disorders: an umbrella review. NPJ Digit Med. 2022 Jul 7;5(1):87. doi: 10.1038/s41746-022-00631-8.

    PubMed 35798934
  • Jan et al.

  • Panicker et al.

Questions about this trial

What is this clinical trial studying?

An observational study of Geriatric Health Services and Health Services for the Elderly, run by Istituto per la Ricerca e l'Innovazione Biomedica at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gennaro Tartarisco (+393283377046, gennaro.tartarisco@irib.cnr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart Rate(HR) (time frame: Through study completion, an average of 1 year). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06490783, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in